Can you take Pepto-Bismol while on Mounjaro?

How Mounjaro's effect on digestion changes the picture

The clinical trial programme behind Mounjaro (the SURMOUNT studies, involving thousands of adults with obesity) documented a consistent pattern: the most frequent side effects were gastrointestinal, peaking in the early weeks of treatment and at each dose step. Nausea, loose stools, indigestion and stomach discomfort were reported by a meaningful proportion of participants, with effects generally tapering as the body adjusted. The mechanism behind this is well established and described in detail on the Mounjaro overview: tirzepatide activates both GIP and GLP-1 receptors, slowing the rate at which the stomach empties food into the small intestine.

That slowing matters for any oral remedy. The NHS patient information for tirzepatide notes that because Mounjaro affects gastric emptying, it can alter the speed at which other orally ingested substances are absorbed. The practical consequence: a remedy you take at the same time as your Mounjaro dose (or even within a few hours) may be absorbed more slowly than usual, and its effects may be delayed or, in theory, altered in intensity.

Pepto-Bismol works primarily in the gut lumen rather than through systemic absorption, which is one reason many pharmacists consider short-term use broadly acceptable. But delayed gastric emptying can still change the timing of its action. Worth knowing before you tuck a bottle in your gym bag for the ride home.

The salicylate question: who should take extra care

Bismuth subsalicylate (the active ingredient in Pepto-Bismol) is chemically related to aspirin. That relationship matters for a specific group of people. Anyone with an aspirin or salicylate allergy, or who has been told to avoid aspirin for any reason, should not use Pepto-Bismol without explicit advice from a pharmacist or GP. The same applies to people with active peptic ulcers, bleeding disorders, or those taking blood thinners or other anti-inflammatory medicines.

Mounjaro is associated with a small but recognised risk of gallbladder-related symptoms, and the MHRA Drug Safety Update communications on GLP-1 medicines flag gastrointestinal symptoms as an area requiring monitoring. If your stomach pain is severe, persistent, or radiates to your back or right shoulder, Pepto-Bismol is not the right response, that warrants prompt medical attention. The same goes for signs of dehydration from repeated vomiting or diarrhoea. Questions about painkillers and other medicines alongside Mounjaro are covered on a separate page about pain relief during treatment.

For most people experiencing ordinary Mounjaro-related nausea, the standard clinical advice is to manage it through eating habits first: smaller portions, slower eating, avoiding very fatty or spicy meals, and keeping well hydrated. These are the first-line recommendations from prescribers before any remedy is added.

Practical guidance on timing and when to ask

If your prescriber or pharmacist has confirmed Pepto-Bismol is appropriate for you, timing matters. Because Mounjaro is injected once weekly rather than taken orally, there is no interaction at the point of administration. The concern is not that Pepto-Bismol interferes with tirzepatide directly but that slowed gut transit may affect how the remedy itself works. Taking it when you genuinely need it (rather than pre-emptively before every meal) is the sensible approach.

Some people on Mounjaro also experience constipation rather than loose stools, particularly at higher doses. Pepto-Bismol can worsen constipation; people in that situation may find a different approach more suitable. Our page on laxatives and Mounjaro covers this in more detail. Separately, if you are considering other supplements during treatment, our page on creatine and Mounjaro addresses one of the most common supplement questions we receive.

The broader principle here applies to any oral product taken alongside tirzepatide: your clinical team needs the full picture. At nume, our prescribers review your health history in detail before approving treatment, and our aftercare team is available seven days a week if questions come up mid-treatment. If you are still exploring whether Mounjaro could be right for you, our treatment overview sets out how the process works from consultation onwards. You can also read about the BMI and eligibility criteria for Mounjaro to understand whether you are likely to qualify. Our clinical team brings the same scrutiny to every repeat order as they do to the first.

The honest answer to this question is that Pepto-Bismol is not automatically off-limits, but it is not automatically fine either. A quick conversation with your pharmacist or prescriber (before you need it) is a small step that removes the guesswork entirely. If you are pregnant or planning to become pregnant, our dedicated page on taking Mounjaro while pregnant covers the specific guidance you will need before making any decisions about treatment. Start your free consultation with us if you have not yet begun treatment and want clinician guidance built in from day one.